Abstract:Abstract BackgroundThe strategy of decreasing atherosclerotic cardiovascular disorder is imperative to reduce premature death and improve quality of life in patients with diabetes mellitus. The present study was designed to investigate whether the natural flavone acacetin could improve diabetes- accelerated atherosclerotic lesions.MethodsDiabetic model was established in 7-week-old ApoE −/− mice by intraperitoneal injection of STZ (daily 50 mg/kg) for 5 days. Animals of control, control with acacetin treatment, STZ-diabetes, STZ-diabetes with acacetin treatment received acacetin prodrug subcutaneously (20 mg/kg, b.i.d.) or equivolume saline for 12 weeks, and the elasticity of carotid artery and the ability of vascular wall movement were determined with ultrasound and magnetic resonance imaging. Human umbilical vein endothelial cells (HUVECs) were cultured with medium containing 5.5 mM or 33 mM glucose and treated with acacetin or vehicle. Changes of related aortic lesions and signaling molecules were determined by biochemical and molecular approaches in animals and cultured HUVECs.ResultsIt was found that acacetin significantly suppressed atherosclerotic lesions and neointima hyperplasia, improved the elasticity of carotid artery and the ability of vascular wall movement without reducing blood glucose level and reversed the impaired signaling molecules (i.e. SOD, Bcl2, PGC-1α, pAMPK, Sirt3 and Sirt1) in artery tissues in diabetic mice. In cultured HUVECs, high glucose-induced cell viability reduction, ROS over-production, decrease of anti-oxidation, increase of apoptosis, and impairment of mitochondrial function were countered by acacetin (0.3-3 µM) in a concentration-dependent manner. Moreover, acacetin relies on Sirt1 activation by increasing NAMPT and NAD + followed by Sirt3, pAMPK and PGC-1α activation. Silencing Sirt1 abolished acacetin-induced activation of Sirt3, pAMPK, and PGC-1α.ConclusionsThese results indicate that Sirt1-mediated activation of pAMPK/Sirt3 signals is involved in protective effects of acacetin against atherosclerosis in diabetes by preserving mitochondrial function via reducing mitochondrial apoptosis and ROS production and enhancing its biogenesis, which suggests that acacetin may be a drug candidate for reducing atherosclerotic cardiovascular disorder in patients with diabetes.

Protective Effects of Acarbose Against Vascular Endothelial Dysfunction Through Inhibiting Nox4/NLRP3 Inflammasome Pathway in Diabetic Rats.

Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1/Nox4 signal pathway in diabetic rats

Argirein Alleviates Vascular Endothelial Insulin Resistance Through Suppressing the Activation of Nox4-dependent O2- Production in Diabetic Rats.

Icariin Attenuates Vascular Endothelial Dysfunction by Inhibiting Inflammation Through GPER/Sirt1/HMGB1 Signaling Pathway in Type 1 Diabetic Rats

Acacetin Protects Against High Glucose-Induced Endothelial Cells Injury by Preserving Mitochondrial Function via Activating Sirt1/Sirt3/AMPK Signals

Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-/AMPK pathway

Ameliorative Effect of Berberine on Endothelial Dysfunction in Diabetic Rats Induced by High-Fat Diet and Streptozotocin

Atherosclerosis is attenuated by acacetin via Sirt1-mediated activation of AMPK/Sirt3 signals in diabetic ApoE-/- mice

Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-α/AMPK pathway

Protection by Simvastatin on Hyperglycemia-Induced Endothelial Dysfunction Through Inhibiting NLRP3 Inflammasomes

Effects of 24-Week Treatment with Acarbose on Glucagon-Like Peptide 1 in Newly Diagnosed Type 2 Diabetic Patients: a Preliminary Report

Anagliptin Ameliorates High Glucose- Induced Endothelial Dysfunction Via Suppression of NLRP3 Inflammasome Activation Mediated by SIRT1

Acid Sphingomyelinase Down‐regulation Alleviates Vascular Endothelial Insulin Resistance in Diabetic Rats

Effects of Antioxidant N-Acetylcysteine on Caveolin-3/eNOS/NO Signaling Pathway in Early Diabetic Rats

CEACAM1 Inhibited IB-/NF-B Signal Pathway Via Targeting MMP-9/TIMP-1 Axis in Diabetic Atherosclerosis

Acacetin Exert Antioxidant Potential Against Atherosclerosis Through Nrf2 Pathway in Apoe-/- Mice

The Antioxidant Edaravone Prevents Cardiac Dysfunction by Suppressing Oxidative Stress in Type 1 Diabetic Rats and in High-Glucose-induced Injured H9c2 Cardiomyoblasts.

Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.

Quercetin modulates AMPK/SIRT1/NF-κB signaling to inhibit inflammatory/oxidative stress responses in diabetic high fat diet-induced atherosclerosis in the rat carotid artery.

Carvacrol improves blood lipid and glucose in rats with type 2 diabetes mellitus by regulating short-chain fatty acids and the GPR41/43 pathway

Gene Cascade Shift and Pathway Enrichment in Rat Kidney Induced by Acarbose Through Comparative Analysis